DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dipyridamole
Dipyridamole
Label (PDF)
THE ROLE of CILOSTAZOL in ISCHEMIC STROKE
In Vitro Modulation of Cisplatin Accumulation in Human Ovarian Carcinoma Cells by Pharmacologic Alteration of Microtubules
MEDICINE to TREAT: HEART DISEASES Antiplatelet Agents Aspirin Dipyridamole Clopidogrel Ticlopidine 1. What Are These Medicines U
Pyridylisatogen Tosylate of ATP-Responses at a Recombinant P2y1 Purinoceptor 1B.F
Clinical Update
Therapeutic Class Overview Platelet Inhibitors
Preventive Drug List
Persantine® (Dipyridamole USP) 25 Mg, 50 Mg, and 75 Mg Tablets
Platelet-Inhibiting Drugs: a Hematologist’S Perspective
Aspirin and Dipyridamole
A Randomized, Controlled Trial Comparing Cilostazol with Extended Release Dipyridamole in the Management of Intermittent Claudication in Peripheral Artery Disease
Adenosine-Mediated Effects of Ticagrelor Evidence and Potential Clinical Relevance
CLINICAL POLICY Regadenoson Pharmacologic Stress Test
Neuraxial Or Nerve Procedures
Enhanced Delivery to Target Cells by Heat-Sensitive Immunoliposomes (Liposome Targeting/Controlled Release) SEAN M
NIH Public Access Author Manuscript Circ Res
These Highlights Do Not Include All the Information Needed to Use ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES Safely and Effectively
Top View
Blood-Thinning Medication After Stroke
Receptor 6 Through Activation of the P2Y Expression in Microglia and Astrocytes -Diphosphate Induces Chemokine ′ Uridine 5
2019 Table of Drugs
Hemodynamic and Neurohumoral Effects of Various Grades of Selective Adenosine Transport Inhibition in Humans. Implications for Its Future Role in Cardioprotection
Preventive Generics Drug List
2018.01 Platelet-Aggregation Inhibitors.Pdf
Cangrelor to Reduce Platelet Aggregation and Thrombosis in Patients Undergoing Percutaneous Coronary Intervention99
Aggrenox and Effient
Modulating Pyrimidine Ribonucleotide Levels for the Treatment of Cancer Tanzina Mollick1,2 and Sonia Laín1,2*
Therapeutic Class Overview Platelet Inhibitors
Phosphorylation of Endothelial NOS Contributes to Simvastatin Protection
Post-Treatment Advice for Patients Taking an Antiplatelet Drug(S) Who to Contact If You Have Concerns About Post- Treatment Bleeding
Aminophylline Shortage and Current Recommendations for Reversal of Vasodilator Stress: an ASNC Information Statement Endorsed By
In Vitro Evaluation of Adenosine 59-Monophosphate As an Imaging Agent of Tumor Metabolism
Myocardial Stress Test
Resistance to Arteriosclerosis in Pigs with Von Willebrand's Disease: SPONTANEOUS and HIGH CHOLESTEROL DIET- INDUCED ARTERIOSCLEROSIS
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Patient Information DIPYRIDAMOLE CAPSULES Safely and Effectively
Antiplatelet Therapies for the Treatment of Cardiovascular Disease
Platelet Aggregation Inhibitors (PDF)
Oral Antiplatelets
Peri-Procedure Management of Antiplatelet Therapy
Environmentally Classified Pharmaceuticals
Anticoagulant and Antiplatelet Medication GL067
Dipyridamole
High Biochemical Selectivity of Tadalafil, Sildenafil and Vardenafil for Human Phosphodiesterase 5A1 (PDE5) Over PDE11A4 Suggest
Personalizing Oral Antiplatelet Therapy in PCI
Pharmaceutical Appendix to the Tariff Schedule 2
Therapeutic Class Overview Platelet Inhibitors
Hemodynamic and Neurohumoral Effects of Various Grades of Selective Adenosine Transport Inhibition in Humans Implications for Its Future Role in Cardioprotection
Update on Antiplatelet Therapy for Peripheral Arterial Disease Current Data and Guidelines for Choosing the Best Pharmacological Option for Each PAD Patient
Antiplatelet Agents for Preventing Vaso-Occlusive Events in People with Sickle Cell Disease: a Systematic Review
Teboroxime in Reperfused Injured Canine Myocardium
Guidelines for the Management of Anticoagulant Agents
Dipyridamole/ASA Shortage
Guidelines for the Administration of Drugs Through Enteral Feeding Tubes
Purinergic Regulation of Bradykinin-Induced Plasma
An NMR Based Phosphodiesterase Assay
Dipyridamole Augments the Antiinflammatory Response During
Antiplatelet Drugs: a Review of Their Pharmacology and Management in the Perioperative Period
Alterations of the Platelet Proteome in Lung Cancer: Accelerated F13A1 and ER Processing As New Actors in Hypercoagulability
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Getting a Lexiscan Stress Test? Skip the Caffeine
Vanderbilt Evidence-Based Practice Center